Oxford BioMedica CEO To Hire More People, Expects More Deals Following Gene Therapy Pact With Axovant

 
• By Sten Stovall
Parkinsons
Duo Aim To Develop And Commercialize OXB-102 Using Oxford BioMedica's LentiVector Platform • Source: Shutterstock

More from Deals

More from Business